Universal Nanosponge for Respiratory Viral Infection Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for coronavirus infections lack effective clinical therapeutics and vaccines, with small molecule antiviral drugs showing unvalidated results, and existing technologies require specific knowledge of viral antigens for targeted therapy.
Innovation Solution
Development of nanoscale particles, termed 'nanosponges,' using plasma membranes from cells infected by coronaviruses, which express receptors for viral entry, allowing broad targeting of coronaviruses without preexisting knowledge of their molecular structure, capable of physically neutralizing viruses and being administered via various routes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibody therapy is used to target viral infections, then specific viral antigens can be neutralized, but the system requires preexisting knowledge of the precise antigenic material and cannot work broadly against new coronavirus strains
Solution Approach 1:
The nanosponge is designed with a universal structure that can target multiple coronavirus strains through conserved entry mechanisms. The sponge's porous structure allows it to bind to various viral entry receptors (ACE-2, TMPRSS2, sialic acid, glycolipids) across different coronavirus families, providing broad-spectrum activity without requiring strain-specific design
Solution Approach 2:
The nanosponge acts as an intermediary substance that intercepts viruses before they can infect host cells. By presenting multiple receptor types on its surface, the sponge serves as a universal mediator that blocks various viral entry pathways, enabling broad targeting without direct knowledge of specific viral antigens
2Productivity
If small molecule antiviral drugs are used, then disease burden may be lessened, but the findings have not been validated and efficacy is uncertain
Solution Approach 1:
The nanosponge system is self-validating through its physical mechanism of action. The sponge's porous structure and receptor-binding capability provide a direct, observable blocking effect that can be validated through simple binding assays and infection models, eliminating the need for complex pharmacological validation required by small molecule drugs
3Reliability
If receptor-specific targeting is used, then viral entry can be blocked, but the system requires identification of specific receptors for each virus strain
Solution Approach 1:
The nanosponge incorporates multiple receptor types (ACE-2, TMPRSS2, sialic acid, glycolipids) on its surface, allowing it to target multiple coronavirus strains through their conserved entry mechanisms. This multi-functional design eliminates the need for strain-specific receptor identification while maintaining effective viral entry blocking
Solution Approach 2:
The system changes the approach from virus-specific to host-cell-specific targeting. Instead of identifying viral receptors, the sponge targets conserved host cell surface markers (such as ACE-2 on respiratory cells) that are universally present across coronavirus strains, simplifying the targeting parameter from viral to host biology
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanosponges effectively neutralize coronaviruses by binding to their entry receptors, preventing cellular infection, and can be stockpiled or rapidly scaled up for production, providing a generalized solution against current and emerging coronavirus strains, including SARS-CoV-2, without relying on specific viral identification.
Implementation Method 1
The nanosponges are capable of binding to and neutralizing viruses because they express the surface receptors employed by the viruses for cellular entry
Implementation Method 2
The membrane material is processed into a nanoparticle by a process such as extrusion, sonication, or microfluidization
Implementation Method 3
The present nanosponges work by physically neutralizing the virus, enabling the pathogen to be effectively cleared by the immune system
Data Source
AI summary
A nanoparticle comprising an outer surface comprising a plasma membrane derived from a cell that can be infected with a respiratory virus, including a human lung epithelial cell expressing ACE-2 receptor. Methods of manufacture and use for preventing or treating viral infections, such as coronavirus infection in a subject in need are disclosed.